MD

SEC source: 0001209191-19-045561 · doc4.xml · nonDerivative · entry 1

FERNANDEZ MICHAEL · CIK 0001218838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,530

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions with prices ranging from $21.35 to $21.82, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this section.

SEC source: 0001209191-19-034352 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,317.22

F1 · kind: Represents 2,144 shares withheld for payment of taxes upon vesting of shares previously reported.

SEC source: 0001209191-19-034374 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,758

F1 · kind: Restricted shares will vest in two equal installments on June 1, 2021 and June 1, 2022.

F2 · balance_after: Includes 191 shares acquired by Reporting Person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing.

SEC source: 0001209191-19-034366 · doc4.xml · nonDerivative · entry 1

MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,534,723

F1 · kind: Represents 24,155 shares withheld for payment of taxes upon vesting of shares previously reported.

SEC source: 0001209191-19-034363 · doc4.xml · nonDerivative · entry 1

Clark David A. · CIK 0001443082 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,657

F1 · kind: Represents 3,307 shares withheld for payment of taxes upon vesting of shares previously reported.

SEC source: 0001209191-19-034358 · doc4.xml · nonDerivative · entry 1

CALABRO JOSEPH M · CIK 0001218834 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 414,679

F1 · kind: Represents 14,729 shares withheld for payment of taxes upon vesting of shares previously reported.

SEC source: 0001209191-19-019780 · doc4.xml · nonDerivative · entry 1

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,821

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in five separate transactions with prices ranging from $30.39 to $30.43 for an average weighted sales price of $30.4033. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-19-018141 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,461.22

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in thirty-one (31) separate transactions with prices ranging from $29.95 to $30.57 for an average weighted sales price of $30.1615. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-19-015105 · doc4.xml · nonDerivative · entry 1

Clark David A. · CIK 0001443082 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,964

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-seven (27) separate transactions with prices ranging from $32.73 to $33.26 for an average weighted sales price of $32.8987. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-19-015103 · doc4.xml · nonDerivative · entry 1

CALABRO JOSEPH M · CIK 0001218834 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 429,408

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in thirty-seven (37) separate transactions with prices ranging from $32.72 to $33.31 for an average weighted sales price of $32.9099. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-19-015664 · doc4.xml · nonDerivative · entry 1

MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,558,878

F1 · kind: Represents 19,331 shares withheld for payment of taxes upon vesting of shares previously reported.

SEC source: 0001209191-19-015104 · doc4.xml · derivative · entry 3

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,584 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-015104 · doc4.xml · nonDerivative · entry 2

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,085

F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 7,489 shares of common stock upon the net exercise of 17,584 stock options with 10,095 shares withheld for payment of the exercise price based on the market price of Issuer's common stock at the time of the option exercise.

SEC source: 0001209191-19-015104 · doc4.xml · nonDerivative · entry 1

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,180

SEC source: 0001209191-19-015106 · doc4.xml · derivative · entry 3

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,584 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-015106 · doc4.xml · nonDerivative · entry 2

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,633

F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 7,628 shares of common stock upon the net exercise of 17,584 stock options with 9,956 shares withheld for payment of the exercise price based on the market price of Issuer's common stock at the time of the option exercise.

SEC source: 0001209191-19-015106 · doc4.xml · nonDerivative · entry 1

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,589

SEC source: 0001209191-19-012605 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,069.22

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in eleven (11) separate transactions with prices ranging from $35.98 to $36.35 for an average weighted sales price of $36.222. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-19-010210 · doc4.xml · nonDerivative · entry 1

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,005

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010208 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,877

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance-based criteria with any shares earned vesting in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

F2 · balance_after: Includes 41 shares that were acquired by Reporting person through Issuer's Employee Stock Purchase Plan.

SEC source: 0001209191-19-010205 · doc4.xml · nonDerivative · entry 1

MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,578,209

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 44,604 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010201 · doc4.xml · nonDerivative · entry 1

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,596

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010190 · doc4.xml · nonDerivative · entry 1

GABOS PAUL G · CIK 0001216803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,596

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010197 · doc4.xml · nonDerivative · entry 1

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,121

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010186 · doc4.xml · nonDerivative · entry 1

FERNANDEZ MICHAEL · CIK 0001218838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,288

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010183 · doc4.xml · nonDerivative · entry 1

FARBER STEPHEN D · CIK 0001205449 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,626

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 17,406 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010176 · doc4.xml · nonDerivative · entry 1

Clark David A. · CIK 0001443082 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,416

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 14,143 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010171 · doc4.xml · nonDerivative · entry 1

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,596

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010167 · doc4.xml · nonDerivative · entry 1

CALABRO JOSEPH M · CIK 0001218834 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 441,538

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 27,198 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010165 · doc4.xml · nonDerivative · entry 1

Barker Karey D · CIK 0001641573 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,061

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010161 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,358.22

F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 7,615 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2019. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-010158 · doc4.xml · nonDerivative · entry 1

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,686

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022.

SEC source: 0001209191-19-004981 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,583

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 sales plan.

SEC source: 0001209191-18-060911 · doc4.xml · nonDerivative · entry 1

Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,845

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. Shares will vest in three installments on December 1, 2019, December 1, 2020 and December 1, 2021.

SEC source: 0001209191-18-060908 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,896.22

F1 · kind: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. Shares will vest in three installments on December 1, 2019, December 1, 2020 and December 1, 2021.

SEC source: 0001209191-18-046822 · doc4.xml · nonDerivative · entry 3

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,583

SEC source: 0001209191-18-046822 · doc4.xml · nonDerivative · entry 2

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,608

SEC source: 0001209191-18-046822 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,148

SEC source: 0001209191-18-037509 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,083

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-three (23) separate transactions with prices ranging from $46.28 to $46.70 for an average weighted sales price of $46.5583. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

F2 · balance_after: Includes 883 shares that were acquired by Reporting person through Issuer's Employee Stock Purchase Plan.

SEC source: 0001209191-18-037504 · doc4.xml · nonDerivative · entry 1

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,590.24

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in sixteen (16) separate transactions with prices ranging from $46.40 to $46.53 for an average weighted sales price of $46.4621. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-18-037500 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,896.22

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-six (26) separate transactions with prices ranging from $46.8950 to $47.05 for an average weighted sales price of $46.9477. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-18-034787 · doc4.xml · nonDerivative · entry 1

CALABRO JOSEPH M · CIK 0001218834 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,747

F1 · kind: Sales made pursuant to Reporting Person's 105b-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in eighty-five (85) separate transactions with prices ranging from $44.50 to $45.88 for an average weighted sales price of $45.1969. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-18-034781 · doc4.xml · nonDerivative · entry 1

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 114,532.24

F1 · kind: Represents 7,395 shares of common stock withheld for payment of taxes upon vesting of shares previously reported.

SEC source: 0001209191-18-034783 · doc4.xml · nonDerivative · entry 1

Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,845

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in seventy-seven (77) separate transactions with prices ranging from $44.50 to $45.95 for an average weighted sales price of $45.1534. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section.

SEC source: 0001209191-18-034775 · doc4.xml · nonDerivative · entry 1

MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,399,792

F1 · kind: Represents 36,386 shares of common stock withheld for payment of taxes upon vesting of shares previously reported.

SEC source: 0001209191-18-033004 · doc4.xml · derivative · entry 3

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2018-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-033004 · doc4.xml · nonDerivative · entry 2

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,896.22

F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 1,857 shares of common stock upon the net exercise of 6,000 stock options with 4,143 shares withheld for payment of the exercise price and taxes, based on the market price of Issuer's common stock at the time of the option exercise.

SEC source: 0001209191-18-033004 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,039.22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-032649 · doc4.xml · derivative · entry 3

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,000 shares

Expires 2018-06-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-18-032649 · doc4.xml · nonDerivative · entry 2

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,716

F1 · kind: Sales made pursuant to Reporting Person's 105b-1 trading plan.